Docket #: S82-068
Hybridomas 3B12, an Anti-Human Leucocyte Reagent, and Hybridoma 4H9, an Anti-Human T Cell Reagent
Hybridoma 4H9 can be used as an antileukocyte reagent capable of recognizing T-cell leukemia and distinguishing it from other forms of acute leukemia. Hybridoma 3B12 can also be used as an antileukocyte reagent distinquishing leukemia lymphoms from other forms of malignancy.
Publications
- Blood Vol. 62, No 4
Similar Technologies
-
Anti-Leu-12 (CD19) Monoclonal Antibody, 4G7 S83-007Anti-Leu-12 (CD19) Monoclonal Antibody, 4G7
-
G-Protein-Linked Receptor-Transfected Lymphoid Cell as Tools for Drug Discovery and for Cellular Therapeutics S95-006G-Protein-Linked Receptor-Transfected Lymphoid Cell as Tools for Drug Discovery and for Cellular Therapeutics
-
Hermes-1, and -3, and other Monoclonal Antibodies to Human CD44 S95-023Hermes-1, and -3, and other Monoclonal Antibodies to Human CD44